噬菌體制劑的研究現(xiàn)狀及發(fā)展前景作者：趙慶友，朱瑞良山東-文庫吧在線文庫
【正文】 therapy:the peculiar kinetics of selfreplicating pharmaceutic als[J]. Clin Pharmacol Ther, 2000, 68(3):225230.[3] Lederberg, in 36:560612.[4] Josslin, studies of the tgene defect in T4infected Escherichia,coli. Virology 44:101107.[5] Chanishvili N,Chanishvili T,Tediashvili M,et and their application against drug resistant Chem Technol Biotechnol,2001,76:689699.[6] Evrard,C.,and structure of the lysozyme from phage lambda and its relationship with V and :151164.[7]Sheehan,.,and lytic enzyme of the pneumococcal phage Dp1:a chimeric lysin of intergeneric origin .:717725.[8]Jado,I.,and lytic enzymes as therapy for antibioticresistant Streptococcus pneumoniae infection in a murine,sepsis, rob. :967973.[9]Loeffler,.,and killing of Streptococcus,pneumoniae with a bacteriophage cell wall 294:21702172[10] Merril CR,Scholl D,Adhya prospect for bacteriophage therapy in Western medicine [J].Nature,2003,2(6):489497.[11]魯會軍,韓文瑜,[J].中國獸藥雜志,2002,36(6):3941.[12] Toshihiro Nakai,Se Chang therapy of infectious diseases in aquaculture [J].Research in Microbiology,2002,153:1318.[13] Kakikawa M,Yokoik I,Kimoto H,et analysis of the lysis protein Lys encoded by Lactobacillus plantrum phage phigle[J].Gene,2002,299(12):227234.[14]Medical news today:Technology to defeat bactierial infection shows positive, lefrom:URL:heep://,2008.[15] Verbeken G,De Vos D,Vaneechoutte M,et regulatory conundrum of phage thera Microbiol,2007,2(5):485491.[16]GrisaruSoen G,Sweed Y,LernerGeva L,et bloodstream infections in a pedi
黨政相關(guān)相關(guān)推薦
鄂ICP備17016276號-1